{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/2451069ea9d4c220086529c4229a4e133e89d52a/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "namespaces_uncached": [],
    "path": "tau/schweig2017.bel",
    "pybel_version": "0.13.2-dev"
  },
  "links": [
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "872b658bd05e999c26fd3eeb76c72a1a0b4a2db85ccfea81b75155d7ec37b28194b1717c63796e1c53efa81694b9914427f9c7f60e8f58a64546462ad8933a2c",
      "line": 93,
      "relation": "increases",
      "source": 15,
      "target": 2
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "eced031c8bd01473e3059f6f730a0a5f9a7213c872f6b8b32542887f28babbd6a726904183d9c0e3dc12141d54a3f9e367da715a7005ecf81715b4389120c016",
      "line": 94,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "To investigate whether pathological Syk activation oc- curs in the brain of AD mouse models, we analyzed the brains of 116-week-old wild-type, Tg APPsw and Tg PS1/APPsw mice using high-resolution confocal micros- copy and immunofluorescence. All transgenic mice (Fig. 1b-e) exhibit an increased Iba-1 and GFAP reactiv- ity compared to wild-type littermates (Fig. 1a). Moreo- ver,wild-type some of the activated amoeboid microglia that are observed in transgenic mice are also strongly positive for pSyk (Fig. 1b-d).",
      "key": "36a8e7b949be4930bed30f5f2d65d875c95a45a7d78d87a77934110696179c70846627e6e9e3817264f5074866a940bf68d87cad366598c9244979e3f13ad15d",
      "line": 94,
      "relation": "positiveCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In addition, we observed that pSyk immunoreactivity is upregulated near A β plaques but neither colocalizes with microglia nor astrocytes suggesting that it could be of neuronal origin. (Fig. 1e). ",
      "key": "84506a68c234e64d1ff4642f0e56a0876cf5249c07185e24a99d605ea86353b7950f5a7ec90d08b134e06e7b14e2ac38ceddc8f5081408195f945993c727bdec",
      "line": 100,
      "relation": "positiveCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In conclusion, activated Syk is not only found in microglia but also in neurons near A β deposits, par- ticularly in dystrophic neurites of Tg APPsw and Tg PS1/APPsw mice supporting a possible role of Syk activation in the formation of dystrophic neurites.",
      "key": "236d5d69ac6701f15f1e86d34511c8b54d47a16b4701a7c1ab768ae495fa8c646bc384a60653abdda1be1b9a06c0413e489843b35c1523da4b56db903a8ae022",
      "line": 111,
      "relation": "positiveCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A β deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "d714abbccf31ecbb3e42b5171d8c70be998befd39247b2702fb811e6f285bee67d52df3f4e01e7b16509c3bb6ba6286d69a34d655643c2c60b698adc45d804d7",
      "line": 252,
      "relation": "positiveCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Dystrophic neurites are characterized by an accumula- tion of BACE-1 and sAPP β [31] and our previous work [28] has shown that Syk regulates BACE-1 expression and sAPP β levels suggesting that Syk upregulation in dystrophic neurites could contribute to the accumulation of BACE-1 and sAPP β .",
      "key": "99995dc2b720b237d3387997cb8d8b9f1f2484b60d5f250f326ecec0e380921e9d0e1cbd92bf962833e82abe8a5efc52fb80844e3bc2867a4fce0c78f16d949b",
      "line": 123,
      "relation": "regulates",
      "source": 14,
      "target": 5
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Dystrophic neurites are characterized by an accumula- tion of BACE-1 and sAPP β [31] and our previous work [28] has shown that Syk regulates BACE-1 expression and sAPP β levels suggesting that Syk upregulation in dystrophic neurites could contribute to the accumulation of BACE-1 and sAPP β .",
      "key": "d3299b3f8f368d02d1ba8a85abef37ed9ab69518a290500e084bb64af59ad2ce05231b93c9fc0188e003f86ba9d401dd1af0f512514636c25c73cbe5b64e5a12",
      "line": 124,
      "relation": "regulates",
      "source": 14,
      "target": 4
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Most importantly, pathological tau species clearly colo- calize with pSyk (Y525/526) in hippocampal neurons (Fig. 4b).",
      "key": "9585471bd94de061ede848d47f2d095ef97964b2b2c6288fb0d1866345e4751a7c3f04e5025f70aa89b11d309d5eb42e8b8883e8531f874c67526a53b57badf8",
      "line": 149,
      "relation": "association",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We observed a colocalization between pSyk and pTau (S202) immuno- reactivities in cortical neurons.",
      "key": "a491bdb7e4d4ab0bb030b3cd085d8c910434caf9d39ec24300f470df30767f7a4f11515c0780c9ff31b60fa4948c6f8656d17c91c557512c7bfaff14fe278665",
      "line": 163,
      "relation": "association",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " In general, we found that neurons that exhibit a high level of pSyk immunoreactivity also demonstrate a higher level of tau pathogenic species whereas neurons that are weakly immunopositive for pSyk show less tau pathology (Figs. 9, 10, 11, 12 and 13).",
      "key": "96ffd7e9b76c5432649f4896940ad3d696c11148bb553f03a79d2d1ad33f3723e21ab4e988762fe31a3f8b722b6014dd40c6f114253b2304b1a9387dc9a99f1a",
      "line": 190,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 0
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Abnormal Syk activation seems to fol- low tau hyperphosphorylation (S202) in the hippocampus of Tg P301S mice (Fig. 6), as well as the formation of MC1-tau pathological conformers (data not shown here but MC1 and pSyk colocalization were quantified below).",
      "key": "6888e1cbed0994b3bb8232e911b73ecf359dbc59cd9d13b79d8770ee1b58994ff3d5ac90f26b3ebbd073f2b04991a9cb667645dc68494baa2a2143ecf4586f5c",
      "line": 172,
      "relation": "association",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 8
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found that tau phosphorylation at Y18 is significantly increased in neurons that are also immunopositive for pSyk (Fig. 10d, p < 0.05) which is consistent with previous data showing that in vitro Syk can phosphorylates tau at Y18.",
      "key": "38e49028550f49bdc9c3eb9aabc18a2d88b86254dccf6948ceac110d00882403156927251ad1a9e9fc90417b3fca66c11dddf3598095b2176d9aa94b6f753c34",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found that tau phosphorylation at Y18 is significantly increased in neurons that are also immunopositive for pSyk (Fig. 10d, p < 0.05) which is consistent with previous data showing that in vitro Syk can phosphorylates tau at Y18.",
      "key": "917efafbba6cce1c72adf3b6533df2e89053a0e00218850743fd4cc96873b0e0f4b380f5afd689935af4e8b1b4c820bf6cba144924a0b884842d2bfe5e244c67",
      "line": 201,
      "relation": "directlyIncreases",
      "source": 14,
      "subject": {
        "effect": {
          "name": "kin",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "456481bb87080b3d93b2f81cfec786de54263a2998e5d96509b2e34280819fe6e259763ed0b6fb4d46e425147eabfc5f57ab49b780f6fbde5e04fe9fe0f38f29",
      "line": 215,
      "relation": "directlyIncreases",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " Interestingly, Syk up- regulation in SH-SY5Y cells leads to a significant in- crease (1.7-fold) in phosphorylated tau at Y18 (Fig. 14c, p < 0.01) and at S396/404 (Fig. 14d, 3-fold, p < 0.0001) compared to control cells.",
      "key": "7173300b2eb40142f6d8efbb2cc1bab2317547f4ee4d5f7cbafb7b0ac93872b9eba253dfde712ce3b5ae36cfdb614987d1e013b5d571657165c3fc26ab84c764",
      "line": 225,
      "relation": "increases",
      "source": 14,
      "target": 12
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A β deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "4490de37969e6d69d386aa3ae8443b10967f5a2a8b11a20897971ed6adc727f221c2e0111b0ee48b6a85a1011490b4219ab4677eb3438a47a16090ee52534e4a",
      "line": 253,
      "relation": "positiveCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We have previously shown that Syk positively regulates GSK-3 β activity in vitro.",
      "key": "460de9959d7de30f7b718c168c7ddc402f64a3bf9c2c3a6f670e9cbbcf391052f796c025ca8149106842494665654619cca1c773b87af8f565733c2239add763",
      "line": 206,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 14,
      "target": 6
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "5bac1664b48611562a0a26b251b7ea2e089be484f4a9890b165826166bf434cd4e9afef6b50d82b57f024e376521b0ef8962454fb6016749135956fccde7fd92",
      "line": 216,
      "relation": "increases",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " Interestingly, Syk up- regulation in SH-SY5Y cells leads to a significant in- crease (1.7-fold) in phosphorylated tau at Y18 (Fig. 14c, p < 0.01) and at S396/404 (Fig. 14d, 3-fold, p < 0.0001) compared to control cells.",
      "key": "31fc909f7abf86970d1404a1e8b53898acb32e3a18829c953a86f8707ea0f5c235e4b9bc557e83efb06a341bfb47920bd67788eaaa635ed73f9f12b01f4b7ade",
      "line": 226,
      "relation": "increases",
      "source": 14,
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "7434b45e70c90ec94b4e89e6c111aaeccc95d4c957295d2e9f4c1ef975d65a77451c0736624711f2cdbca57de086446f4260406f32d2020d209586c314923b44",
      "line": 217,
      "relation": "increases",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "28cc63e6d31dcdc6f217fc0969c6a8fe2f24d34068284f1eb3f4918e1d98e8b2eef5791cd898f5702b1f2d4cb0d5935f85816c40678c22abdc2ff98ba6c06038",
      "line": 218,
      "relation": "increases",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A β deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "665ec37c66d90634a6636f418da2d84e9d7799f94d410662de92bd634a9e1d5e48cc2d6c9f2b124b3be84936dc5cb4baef2fad1c5a2199c31f8f453df0ce378b",
      "line": 254,
      "relation": "positiveCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 9
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " Total tau levels are also sig- nificantly increased following Syk overexpression (Fig. 14e, 4.2-fold, p < 0.0001). ",
      "key": "4c4ffd004136d58c6b1ac2b68691704ac337922e214eb44494975759de50d77b1be904a94f4060eb0fb512882935d6b6d53114582b60ef6f66c5ba160eb867b7",
      "line": 231,
      "relation": "increases",
      "source": 14,
      "target": 7
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "We analyzed the possible impact of Syk overexpression on Tau mRNA levels by quantitative RT-PCR and found that Syk overexpression does not affect Tau transcription (data not shown) sug- gesting that Syk may regulate tau degradation or tau protein translation.",
      "key": "d46b64d9ff5253a3e2c9012105c959455b7ac955b75c1f59331df7b1dc3392128ac8dbea0f5a47c2ee1a15591ae57918eb38f7a966bbc9a321d7b54916fe37aa",
      "line": 239,
      "relation": "causesNoChange",
      "source": 14,
      "target": 16
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In addition, we observed that pSyk immunoreactivity is upregulated near A β plaques but neither colocalizes with microglia nor astrocytes suggesting that it could be of neuronal origin. (Fig. 1e). ",
      "key": "0ccd8f4cb8617059bb0955fc3f9320fa5ef54f014dc2e3f226394ed5d1e2223bda236f199a6afaec07b757dfcef4f4c3c436305bfd274c5fe5c677f4757b9068",
      "line": 100,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In conclusion, activated Syk is not only found in microglia but also in neurons near A β deposits, par- ticularly in dystrophic neurites of Tg APPsw and Tg PS1/APPsw mice supporting a possible role of Syk activation in the formation of dystrophic neurites.",
      "key": "7940f72ec42c0833418fcf37c4a6e5ad9de6782786ecf85b9526339a295c3b8615b7a54b51cff2605e65d0470d6e302a062c15531a688c927ec7f40f71169b1c",
      "line": 111,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A β deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "8956a363d2b52460e0a8485aa823223e3c012e134ccf0159cc8b314a308d343e70f621cd8694b3a8cada44428c7319db513a8afcf198b292085060b69a50cb6f",
      "line": 252,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "In contrast, microscopic fields of older Tg APPsw mice containing A β deposits exhibit a strong increase in pSyk burden (799.95 ± 130.19%) com- pared to age-matched WT mice. ",
      "key": "ccb64a3e643e264177b93837b96d94fe7f76612e06efd9006d056dfc3ea0ba1050a0c7f89e48387d99d118e7b63045927a37d07269d8d62390a889ce8234db4b",
      "line": 133,
      "relation": "increases",
      "source": 3,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Cortical neurons of Tg Tau P301S mice also show an in- crease in tau hyperphosphorylation and pSyk with age (Fig. 7). ",
      "key": "0faab80616e2194cb225d4ae0a4707d2e2f37a65960f1f887c41ab7b3b52fc1584ffd2c231f820070dcdd52781bd738745d89209115a85acfdc99d05830a7b31",
      "line": 181,
      "relation": "increases",
      "source": 3,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Cortical neurons of Tg Tau P301S mice also show an in- crease in tau hyperphosphorylation and pSyk with age (Fig. 7). ",
      "key": "92c447474f3973ce1a48dfbebf480800db08bbe34afa28049c5d718a99f7535899da52f19f02c8a992c1c65b3849f7e060b9e93eb935886cc3eb136b99e4d267",
      "line": 180,
      "relation": "increases",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Hippocampal neurons of Tg Tau P301S mice exhibit a high level of tau hyperphosphorylation (Fig. 4b) as well as an accumulation of pathogenic tau conformers (MC1, not shown) compared to WT littermates (Fig. 4a).",
      "key": "2474139dbd1c2f90b93c817f718135260385a5e2ca50937ac7dffa14ad9ffe82092e2cc57c1e30c3260c6dc9af8de10d6ea1e661dcdc2ec137f2be898d1b9b46",
      "line": 141,
      "relation": "increases",
      "source": 13,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Cortical neurons of Tg Tau P301S mice also exhibit an increased level of tau hyperphosphorylation (Fig. 5b) compared to wild-type littermates (Fig. 5a).",
      "key": "30fbe7e90a6fcd0d1ec313d74519fd5a5571e401227a0a41917d0497a12eeefb190e5f81a8143e0075296f3ac13964de9e2c9ae076eb1855e10c530c756fc331",
      "line": 156,
      "relation": "increases",
      "source": 13,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Hippocampal neurons of Tg Tau P301S mice exhibit a high level of tau hyperphosphorylation (Fig. 4b) as well as an accumulation of pathogenic tau conformers (MC1, not shown) compared to WT littermates (Fig. 4a).",
      "key": "bc51f1f17d3f296e11293dc6d417c417c08905370c6df66ed494d32224cc8a4f3f6227f10a20a79b819567159f0c8a9afffa74cab5c1c283815b8b81d9b55f0b",
      "line": 142,
      "relation": "increases",
      "source": 13,
      "target": 0
    },
    {
      "key": "427a39437aea06845d630b8661247d2d66da94393818d49f37598de82807414c0b4813eaae08492083dbc80d0e50cf49b60d5cdc7dc68673446f1e391b2342fa",
      "relation": "hasVariant",
      "source": 7,
      "target": 13
    },
    {
      "key": "9fbd9218812f1cd82827e2d73f3b6af04acbe1f408aaedcdc53c6fc17a36272c67cdcc254874f5473ba4443fa19971fe4877420e735c04f4f7353480d8e1f8b2",
      "relation": "hasVariant",
      "source": 7,
      "target": 8
    },
    {
      "key": "9cfb692e3b39903e05776d10e5ec184405b65b7ee2afbee7a958ac60be2e0a8de0d684efe5a7fcc4198d4d76591b906798952e7cda8584eb982d9758803184ed",
      "relation": "hasVariant",
      "source": 7,
      "target": 12
    },
    {
      "key": "0efa2343a1aab409feeae95a44c4251f713383a6e606f151efb4055e8f77a89d772738244ac3792bc5938f0fe885967c3489d8612cccddfd37a4a5dd7ed7c968",
      "relation": "hasVariant",
      "source": 7,
      "target": 11
    },
    {
      "key": "57f6dfc4cb18d002fb185a5f8ddb26897f5c0e93f59d9f1ee55374a026a04da6c975e40dd70e3f890ef9f9793c8b77bf916ea47533ecfee045a95797915ad8ba",
      "relation": "hasVariant",
      "source": 7,
      "target": 10
    },
    {
      "key": "90b589893ab291da8b432c788632d3df36cb31613b59eb0863f47fc58dc4fdcef450b96b7b20ae514090513ac35ed407e8a88acd562ae5e5aff4ef0c3bbcdf9e",
      "relation": "hasVariant",
      "source": 7,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Abnormal Syk activation seems to fol- low tau hyperphosphorylation (S202) in the hippocampus of Tg P301S mice (Fig. 6), as well as the formation of MC1-tau pathological conformers (data not shown here but MC1 and pSyk colocalization were quantified below).",
      "key": "55906d3eb103aa88457ea4284e03941e343662c579c076612169d958725a5be6e1aeadea043243c487edb2b4b6059a2ea0155636291fbe00446e0b7af317343e",
      "line": 172,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 8,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Abnormal Syk activation seems to fol- low tau hyperphosphorylation (S202) in the hippocampus of Tg P301S mice (Fig. 6), as well as the formation of MC1-tau pathological conformers (data not shown here but MC1 and pSyk colocalization were quantified below).",
      "key": "41b88ac3a123e22275f2ea85ae75720b7915c74e96f159b37135532988480483ad08968e56dce3c1ad307fa900ed03962d7786f6fd4ed1a57a193fc5e1c191a5",
      "line": 173,
      "relation": "association",
      "source": 8,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "hippocampal neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Most importantly, pathological tau species clearly colo- calize with pSyk (Y525/526) in hippocampal neurons (Fig. 4b).",
      "key": "21d91bc35a507194405e0e25d917080b87ffb1c4f0a3a56e9509d1f7d74a618ea56d0f14dcd9cd5f8c1563b08dcf5c5c76f7d0dd3902da1c82126a7b35e27848",
      "line": 149,
      "relation": "association",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "cerebral cortex neuron": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We observed a colocalization between pSyk and pTau (S202) immuno- reactivities in cortical neurons.",
      "key": "380361243198ae5264c6f21c2294a385e992e123f0b2899fa628d536c34a50f630a1888d2134038246e5a9471df7d5e6f1111423e39dc9e60c11efc2a84fb74d",
      "line": 163,
      "relation": "association",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " In general, we found that neurons that exhibit a high level of pSyk immunoreactivity also demonstrate a higher level of tau pathogenic species whereas neurons that are weakly immunopositive for pSyk show less tau pathology (Figs. 9, 10, 11, 12 and 13).",
      "key": "e0015e9b8156d12e66cea87224ba5f91bae3165357ded53c764f61224f4abb620f41d53ce67db66c3189e65bfe81e5789fe0a6f1065b88622c6ed776b450769f",
      "line": 190,
      "relation": "positiveCorrelation",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Abnormal Syk activation seems to fol- low tau hyperphosphorylation (S202) in the hippocampus of Tg P301S mice (Fig. 6), as well as the formation of MC1-tau pathological conformers (data not shown here but MC1 and pSyk colocalization were quantified below).",
      "key": "2614ad1d561aceaed3b1ba1eaeff05765bef3e27a1357e53ce38db62af243ca164567be20c5ede80c758b231481c52479477afb63dc6f5b6adbe879699e6bf9e",
      "line": 173,
      "relation": "association",
      "source": 0,
      "target": 8
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found that tau phosphorylation at Y18 is significantly increased in neurons that are also immunopositive for pSyk (Fig. 10d, p < 0.05) which is consistent with previous data showing that in vitro Syk can phosphorylates tau at Y18.",
      "key": "1dbf0efbd9586c48473878ea48d06203ba7754fa33b3f79669dd10981ede791120bdaac7e747256b756aa5d39a92d2660bbddd4139dada5539ee2f2eeca5da48",
      "line": 199,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": "Altogether, these data suggest that only certain pathogenic forms of tau (MC1, Y18) promote Syk activation, whereas Syk activation appears to directly in- duce tau phosphorylation at Y18 and to indirectly regulate tau phosphorylation at multiple epitopes (S396/404, S202) as well as tau misfolding (MC1, TOC1).",
      "key": "38fc59b21e08f8ec22559e5dba39d006d65a4595aaed737ba5a76be6d5d9966710c2d8296829c830717b0438e937490fb55213f4835f07addb0cbb6e89a3afdd",
      "line": 214,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 12,
      "target": 14
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A β deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "695a07776a2368aab89f0ddb2a0e6a38955325bc3296cd8c22a7140af434f0560c6de5a3707750b4e36c17c82b7ca140f08af8cc16c9308992e0e7d0a64fc30b",
      "line": 253,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 14
    },
    {
      "annotations": {
        "CellStructure": {
          "Neurites": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mouzon B",
          "Mullan M",
          "Paris D",
          "Schweig JE",
          "Yao H"
        ],
        "date": "2017-09-06",
        "first": "Schweig JE",
        "last": "Paris D",
        "name": "Acta neuropathologica communications",
        "pages": "69",
        "reference": "28877763",
        "title": "Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.",
        "type": "PubMed",
        "volume": "5"
      },
      "evidence": " We found an increase in Syk activation in DNs surrounding A β deposits as well as in neurons displaying an accumu- lation of phosphorylated Tau at Y18 and elevated levels of MC1 pathogenic tau conformers in AD brain sections whereas only weak immunoreactivity for pSyk was ob- served in brain sections from a non-demented control (Figs. 15, 16 and 17).",
      "key": "ddfe624b94ffa098b1d4d98753cca6090bf2c460348a662fe43a649a556ceb2f3980cd6784643a8c25d1b4de17efc085ba921049c819a455382f05e6a28f4657",
      "line": 254,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 14
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(HBP:\"Tau aggregates\")",
      "function": "Abundance",
      "id": "2f93b798e33773ea9681389870bbee41f6fa7ee04c087bda4bd1492520385f58d089a7261b1353e15c31d3e29a96ff31884886e6ab9fa477ef8f63f19cf154f7",
      "name": "Tau aggregates",
      "namespace": "HBP"
    },
    {
      "bel": "a(HBP:\"amyloid-beta aggregates\")",
      "function": "Abundance",
      "id": "1d739f6eba3532950fc068e81f7aea675ce76d42a049b5a301ad8bccf2f503d6c2a79c9d417d4d35cc760c340b5db2513536b3c420156a92bda3605be3537740",
      "name": "amyloid-beta aggregates",
      "namespace": "HBP"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "function": "BiologicalProcess",
      "id": "9e9682b78aa06bbcb9dae35006f6da468e11928c000097001cd665b1bedf3c75ef887ecd7781ef3c545cafb3780cb7afabec9bfc70e14a48149d8adee8502981",
      "name": "microglial cell activation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:aging)",
      "function": "BiologicalProcess",
      "id": "e656a7a9b8877eca28efc8bcece0149b9f17b643e48c2ae605fb3977fb925968220ed9a29a1649919bd2bdbfd43e6cd082182ead002a6eb840cd3f1e4f57d213",
      "name": "aging",
      "namespace": "GO"
    },
    {
      "bel": "p(HBP:\"sAPP-beta\")",
      "function": "Protein",
      "id": "5f1801ec0c9b3dadc727542d1599d75009fa94146d16089405e295556502387876deb8a7703f4c9d2d907e27459dcff4420cee93532d3263747f34d122592482",
      "name": "sAPP-beta",
      "namespace": "HBP"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "function": "Protein",
      "id": "88f17e7dffb6947c01414f79e5a3bb9cdd3e932c355af7f0c8907d2b5d07742883eaf63866fe7fc938401ce0c366856fd5e306f324e6c1f474c1a984c8e46a51",
      "name": "BACE1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "function": "Protein",
      "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c",
      "name": "GSK3B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(HBP:hyperphosphorylation))",
      "function": "Protein",
      "id": "ede67fb639f29861d91976fefa16d8279b53ae13a659f35d70ed12e01bf3f339ffcf701fc54c7c4e908fee9902c02aac3e0022dcae5a7afa217ed2d4dba133b0",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "hyperphosphorylation",
            "namespace": "HBP"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(HBP:misfolded))",
      "function": "Protein",
      "id": "ecfcb63ffa4e25322a36f440d3724bb450fc6d9ec496f8cd7c66f53a282dbffac579d5bca7b6e04df3ee3d7e3449e11776da8bfb6b14907fe46211e64326a6ff",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "misfolded",
            "namespace": "HBP"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 202))",
      "function": "Protein",
      "id": "49b56446b699c749fbb01c4560254bbf621f44bd52a02cb74e212fb0ef1b9b1616a31cfe6ca06023fee3689ef552a3e8fe71211987ebad4180c2d78535f4ad7a",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 202
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396), pmod(Ph, Ser, 404))",
      "function": "Protein",
      "id": "39bce9d17a0e3ef84038e06e52460d0a74f6adb7a3bffaba4858b8ada9ad6cc683cfaf93b6bb11e329e2818937b3cb05c7bb618018d5bf2b718fbfcadcd03af5",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        },
        {
          "code": "Ser",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 404
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Tyr, 18))",
      "function": "Protein",
      "id": "5b045c071b780caaf6d0a4441b95389b9857364de91d6676af9d7497e2f4fd2ceda3e2ac4bb7f5e526690284a133fa5fce968527f72d8e1582029f1551a0c7bc",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "code": "Tyr",
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 18
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, var(\"p.Pro301Ser\"))",
      "function": "Protein",
      "id": "fdefb9fccd419a680b6a483b61369698122adfd362204e80da9f615bcec85a7344a6eaa9a4227f5a4d1a549615ca53db17a685ade8e5c00bce64a93850284361",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Pro301Ser",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SYK)",
      "function": "Protein",
      "id": "b0e9f727ba248d29d2019ec99a224ad35dd135d47bfa484f337a0769a1128f55c07c65e3af1d5377432da22220aae827b56233bafd024a629300d6aafcbf0996",
      "name": "SYK",
      "namespace": "HGNC"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "r(HGNC:MAPT)",
      "function": "RNA",
      "id": "54fd242f396c4644b46548885bfbc0e1c22320972c8b0b6c3008a5a1d9152f5a5287d81a693f85e739f039db27862a857420216fe3eb25d300f63e68d47cdad3",
      "name": "MAPT",
      "namespace": "HGNC"
    }
  ]
}